Viewing Study NCT06105632


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-03-06 @ 3:17 PM
Study NCT ID: NCT06105632
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2023-10-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: C4391022
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators